{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:47:54Z","timestamp":1782532074159,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072296"],"award-info":[{"award-number":["82072296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004476","name":"Chinese Center for Disease Control and Prevention","doi-asserted-by":"publisher","award":["ZDWNLJS25-37"],"award-info":[{"award-number":["ZDWNLJS25-37"]}],"id":[{"id":"10.13039\/501100004476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004476","name":"Chinese Center for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2022YFC2604101"],"award-info":[{"award-number":["2022YFC2604101"]}],"id":[{"id":"10.13039\/501100004476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tvr.2026.200341","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T11:24:16Z","timestamp":1775388256000},"page":"200341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends"],"prefix":"10.1016","volume":"21","author":[{"given":"Dongbo","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3442-9550","authenticated-orcid":false,"given":"Xuexin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2026.200341_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.tvr.2026.200341_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.tvr.2026.200341_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tvr.2026.200341_bib4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/488S2a","article-title":"HPV: the global burden","volume":"488","author":"Crow","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tvr.2026.200341_bib5","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3390\/v13122460","article-title":"HPV16 entry into epithelial cells: running a gauntlet","volume":"13","author":"Mikuli\u010di\u0107","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.tvr.2026.200341_bib6","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1128\/JVI.79.11.6741-6750.2005","article-title":"Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2026.200341_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrg2323","article-title":"Rates of evolutionary change in viruses: patterns and determinants","volume":"9","author":"Duffy","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tvr.2026.200341_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2013.05.012","article-title":"Evolution of the papillomaviridae","volume":"445","author":"Van Doorslaer","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2026.200341_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099488","article-title":"Roles for human Papillomavirus Type 16 L1 Cysteine Residues 161, 229, and 379 in Genome Encapsidation and Capsid Stability","volume":"9","author":"Ryndock","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tvr.2026.200341_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01819-22","article-title":"Critical residues involved in the coassembly of L1 and L2 capsid proteins of human papillomavirus 16","volume":"97","author":"Chen","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2026.200341_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145533","article-title":"Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency","volume":"782","author":"Oumeslakht","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.tvr.2026.200341_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/21645515.2018.1512453","article-title":"Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature","volume":"15","author":"Hirth","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.tvr.2026.200341_bib13","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1073\/pnas.1515528113","article-title":"National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States","volume":"113","author":"Durham","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tvr.2026.200341_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1902","article-title":"Human papillomavirus vaccine effectiveness and herd protection in young women","volume":"143","author":"Spinner","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.tvr.2026.200341_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","article-title":"Human papillomavirus prevalence and herd immunity after introduction of vaccination Program, Scotland, 2009\u20132013","volume":"22","author":"Cameron","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tvr.2026.200341_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/vaccines9121413","article-title":"Human papillomavirus vaccine efficacy and effectiveness against cancer","volume":"9","author":"Kamolratanakul","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.tvr.2026.200341_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2019.06.006","article-title":"Human papillomavirus vaccine disease impact beyond expectations","volume":"39","author":"De Sanjose","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.tvr.2026.200341_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/infdis\/jix274","article-title":"Naturally occurring single amino acid substitution in the L1 major capsid protein of human papillomavirus type 16: alteration of susceptibility to antibody-mediated neutralization","volume":"216","author":"Ning","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tvr.2026.200341_bib19","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/infdis\/jiz401","article-title":"Sensitivity of human papillomavirus (HPV) lineage and sublineage variant pseudoviruses to neutralization by nonavalent vaccine antibodies","volume":"220","author":"Godi","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tvr.2026.200341_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep15751","article-title":"Identification and validation of immunogenic potential of India specific HPV-16 variant constructs: In-silico & in-vivo insight to vaccine development","volume":"5","author":"Kumar","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvr.2026.200341_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.6026\/97320630013241","article-title":"Naturally occurring capsid protein variants L1 of human papillomavirus genotype 16 in Morocco","volume":"13","author":"El-Aliani","year":"2017","journal-title":"Bioinformation"},{"key":"10.1016\/j.tvr.2026.200341_bib22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.tvr.2026.200341_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1385\/1-59259-982-6:445","article-title":"Generation of HPV pseudovirions using transfection and their use in neutralization assays","volume":"119","author":"Buck","year":"2005","journal-title":"Human Papillomaviruses"},{"key":"10.1016\/j.tvr.2026.200341_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1097-2765(00)80449-9","article-title":"Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16","volume":"5","author":"Chen","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tvr.2026.200341_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01104-14","article-title":"Maturation of the human papillomavirus 16 capsid","volume":"5","author":"Cardone","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.tvr.2026.200341_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.str.2016.12.001","article-title":"Cryoelectron microscopy maps of human papillomavirus 16 reveal L2 densities and heparin binding site","volume":"25","author":"Guan","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.tvr.2026.200341_bib27","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1038\/s41598-021-83076-5","article-title":"High resolution cryo EM analysis of HPV16 identifies minor structural protein L2 and describes capsid flexibility","volume":"11","author":"Goetschius","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvr.2026.200341_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.virol.2015.04.016","article-title":"Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization","volume":"483","author":"Guan","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2026.200341_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/v9120374","article-title":"High-Resolution structure analysis of antibody V5 and U4 conformational epitopes on human papillomavirus 16","volume":"9","author":"Guan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.tvr.2026.200341_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41541-020-00236-w","article-title":"Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs","volume":"5","author":"Huang","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.tvr.2026.200341_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72491-z","article-title":"Exploring the ability of the MD+FoldX method to predict SARS-CoV-2 antibody escape mutations using large-scale data","volume":"14","author":"Chi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvr.2026.200341_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-2836(02)00442-4","article-title":"Predicting changes in the stability of proteins and protein complexes: a Study of more than 1000 mutations","volume":"320","author":"Guerois","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.tvr.2026.200341_bib33","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/jvi.67.12.6929-6936.1993","article-title":"Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles","volume":"67","author":"Kirnbauer","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2026.200341_bib34","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/s41467-020-16639-1","article-title":"Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tvr.2026.200341_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"WJV"},{"key":"10.1016\/j.tvr.2026.200341_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105549","article-title":"Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology","volume":"146","author":"Zhang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.tvr.2026.200341_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mcp.2012.01.002","article-title":"Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals","volume":"26","author":"Dauner","year":"2012","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.tvr.2026.200341_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/molbev\/msz197","article-title":"HyPhy 2.5\u2014A customizable platform for evolutionary Hypothesis testing using phylogenies","volume":"37","author":"Kosakovsky Pond","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.tvr.2026.200341_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/vaccines12040421","article-title":"Impact of HPV vaccination on the incidence of high-grade Cervical Intraepithelial Neoplasia (CIN2+) in women aged 20\u201325 in the Northern part of Norway: a 15-Year Study","volume":"12","author":"Mikalsen","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.tvr.2026.200341_bib40","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1099\/jgv.0.000829","article-title":"Impact of naturally occurring variation in the human papillomavirus (HPV) 33 capsid proteins on recognition by vaccine-induced cross-neutralizing antibodies","volume":"98","author":"Godi","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tvr.2026.200341_bib41","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.vaccine.2020.11.076","article-title":"Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence","volume":"39","author":"Brown","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tvr.2026.200341_bib42","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.molmed.2024.05.009","article-title":"HPV integration and cervical cancer: a failed evolutionary viral trait","volume":"30","author":"Molina","year":"2024","journal-title":"Trends Mol. Med."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679026000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679026000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:42:34Z","timestamp":1782531754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679026000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"alternative-id":["S2666679026000054"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2026.200341","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2026.200341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200341"}}